|
ZFP161 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.956000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.476200E-01 |
| Normal-vs-Stage2 |
7.870200E-01 |
| Normal-vs-Stage3 |
5.210100E-02 |
| Normal-vs-Stage4 |
1.878400E-03 |
| Stage1-vs-Stage2 |
9.803800E-01 |
| Stage1-vs-Stage3 |
9.230200E-02 |
| Stage1-vs-Stage4 |
7.557700E-03 |
| Stage2-vs-Stage3 |
1.570380E-01 |
| Stage2-vs-Stage4 |
2.812000E-02 |
| Stage3-vs-Stage4 |
5.078400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.747400E-01 |
| Normal-vs-AfricanAmerican |
8.257000E-01 |
| Normal-vs-Asian |
5.329600E-02 |
| Caucasian-vs-AfricanAmerican |
8.164000E-01 |
| Caucasian-vs-Asian |
3.344400E-01 |
| AfricanAmerican-vs-Asian |
2.334400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.940800E-01 |
| Normal-vs-Female |
7.244400E-01 |
| Male-vs-Female |
3.174600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.738200E-01 |
| Normal-vs-Extreme_Weight |
3.837600E-01 |
| Normal-vs-Obese |
6.607000E-01 |
| Normal-vs-Extreme_Obese |
3.761200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.008600E-01 |
| Normal_Weight-vs-Obese |
8.311800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.602200E-01 |
| Extreme_Weight-vs-Obese |
6.923400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.936000E-01 |
| Obese-vs-Extreme_Obese |
5.057000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.110190E-01 |
| Normal-vs-Age(41-60Yrs) |
4.102000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.185800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.199600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.024100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.765200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.338000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.622200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.395400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.959600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.596600E-01 |
| Normal-VS-Type2 PRCC |
7.584600E-03 |
| Normal-VS-KIRP CIMP |
2.00509999999099E-05 |
| Normal-VS-Unclassified PRCC |
9.574600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.037000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.9747000035153E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
5.082200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.435800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.143700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.569700E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.244200E-03 |
| Normal-vs-N1 |
3.392000E-02 |
| Normal-vs-N2 |
9.256400E-03 |
| N0-vs-N1 |
9.653000E-01 |
| N0-vs-N2 |
2.462800E-01 |
| N1-vs-N2 |
5.790300E-02 |
|
|
